Recent advances in therapeutic strategies for non-small cell lung cancer by Po-Lan Su, Naoki Furuya, Alahmadi Asrar, Christian Rolfo, Zihai Li, David P. Carbone, Kai He

Get full text

Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting. by Amy P Abernethy, Ashwini Arunachalam, Thomas Burke, Caroline McKay, Xiting Cao, Rachael Sorg, David P Carbone

Get full text

Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications by David P Carbone, Igor Puzanov, Ronan J Kelly, Yuval Shaked, Michal Harel, Coren Lahav, Eyal Jacob, Nili Dahan, David R Gandara, Yehonatan Elon, Adam P Dicker, Raya Leibowitz

Get full text

Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients by Anet Greib, Songzhu Zhao, Michelle Ploch, Jonathan Henricks, Robert Easterling, Meghana Moodabagil, Gabrielle Lopez, Mingjia Li, Evelyn G. Goodyear, John Sharp, Asrar Alahmadi, Jacob Kaufman, Regan Memmott, Kai He, Peter Shields, David P. Carbone, Gregory A. Otterson, Carolyn J. Presley, Lai Wei, Dwight H. Owen, Kevin Ho

Get full text

Trends in Mesothelioma Mortality in the United States Between 1999 and 2020 by Alexander J. Didier, BS, Mingjia Li, MD, Jinesh Gheeya, MD, PhD, Asrar Alahmadi, MD, Jacob Kaufman, MD, PhD, Regan Memmott, MD, PhD, Kai He, MD, PhD, Peter Shields, MD, David P. Carbone, MD, PhD, Carolyn Presley, MD, Dwight Owen, MD, MS, Logan Roof, MD, MS

Get full text

An in vivo “turning model” reveals new RanBP9 interactions in lung macrophages by Yasuko Kajimura, Shuxin Dong, Anna Tessari, Arturo Orlacchio, Alexandra Thoms, Maria Concetta Cufaro, Federica Di Marco, Foued Amari, Min Chen, Shimaa H. A. Soliman, Lara Rizzotto, Liwen Zhang, Damu Sunilkumar, Joseph M. Amann, David P. Carbone, Amer Ahmed, Giuseppe Fiermonte, Mike A. Freitas, Alessia Lodi, Piero Del Boccio, Lino Tessarollo, Dario Palmieri, Vincenzo Coppola

Get full text

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types by Vivek Subbiah, Samuel J Klempner, Neeraj Agarwal, David P Carbone, Amit Mahipal, Shilpa Gupta, David Fabrizio, Jeffrey S Ross, Gerald Li, David R Gandara, Miles C Andrews, Jonathan W Riess, Ramez N Eskander, Ryon P Graf, Geoffrey R Oxnard, Sarah Sammons, Jeremy Snider, Lilia Bouzit, Cheryl Cho-Phan, Megan Price, Julia C F Quintanilha, Richard Sheng Poe Huang

Get full text

Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non‐Small‐Cell Lung Cancer Treated With Front‐Line Immunotherapy‐Based Therapies by Mingjia Li, Po‐Lan Su, Songzhu Zhao, Grace Cheng, Nicholas Jones, Kenneth Chian, Natalie Johns, Adam Khorasanchi, Adeoluwa Adeluola, Annastasia Petouhoff, Daniel J. Spakowicz, Lai Wei, Xiaoying Wang, Christopher Coss, Mitch A. Phelps, Lingbin Meng, Yuanquan Yang, Alexa Meara, Mohamed I. Elsaid, Jinesh Gheeya, Logan Roof, Asrar Alahmadi, Regan M. Memmott, Jacob Kaufman, Kai He, Carolyn J. Presley, Peter G. Shields, David P. Carbone, Gregory A. Otterson, Jason Prosek, Dwight H. Owen

Get full text